DE60316389D1 - Verwendung von Hederagenin 3-O-alpha-L-rhamnopyranosyl((1->2)-Äbeta-D-glucopyranosyl(1->4)Ü-alpha-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als therapeutisches Mittel für solide Tumore - Google Patents

Verwendung von Hederagenin 3-O-alpha-L-rhamnopyranosyl((1->2)-Äbeta-D-glucopyranosyl(1->4)Ü-alpha-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als therapeutisches Mittel für solide Tumore

Info

Publication number
DE60316389D1
DE60316389D1 DE60316389T DE60316389T DE60316389D1 DE 60316389 D1 DE60316389 D1 DE 60316389D1 DE 60316389 T DE60316389 T DE 60316389T DE 60316389 T DE60316389 T DE 60316389T DE 60316389 D1 DE60316389 D1 DE 60316389D1
Authority
DE
Germany
Prior art keywords
alpha
arabinopyranoside
hederagenin
rhamnopyranosyl
glucopyranosyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316389T
Other languages
English (en)
Other versions
DE60316389T2 (de
Inventor
Song-Bae Kim
Byung-Zun Ahn
Yong Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE60316389D1 publication Critical patent/DE60316389D1/de
Application granted granted Critical
Publication of DE60316389T2 publication Critical patent/DE60316389T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60316389T 2002-07-22 2003-07-03 Verwendung von Hederagenin-3-O-a-L-rhamnopyranosyl((1->2)-(ß-D-glucopyranosyl (1->4))-a-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als ein therapeutisches Mittel für solide Tumore Expired - Lifetime DE60316389T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020020043016A KR100568607B1 (ko) 2002-07-22 2002-07-22 헤데라게닌3-O-α-L-람노피라노실(1→2)-[β-D-글루코피라노실(1→4)]-α-L-아라비노피라노사이드 또는 그를 함유하는백두옹 추출물의 고형암 치료제로서의 용도
KR2002043016 2002-07-22

Publications (2)

Publication Number Publication Date
DE60316389D1 true DE60316389D1 (de) 2007-10-31
DE60316389T2 DE60316389T2 (de) 2008-06-26

Family

ID=30439383

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316389T Expired - Lifetime DE60316389T2 (de) 2002-07-22 2003-07-03 Verwendung von Hederagenin-3-O-a-L-rhamnopyranosyl((1->2)-(ß-D-glucopyranosyl (1->4))-a-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als ein therapeutisches Mittel für solide Tumore

Country Status (15)

Country Link
US (3) US20040082528A1 (de)
EP (1) EP1388542B1 (de)
JP (1) JP4642330B2 (de)
KR (1) KR100568607B1 (de)
CN (1) CN1308000C (de)
AT (1) ATE373670T1 (de)
AU (1) AU2003208120B2 (de)
BR (1) BR0302590A (de)
CA (1) CA2435524C (de)
DE (1) DE60316389T2 (de)
DK (1) DK1388542T3 (de)
ES (1) ES2292883T3 (de)
MX (1) MXPA03006473A (de)
RU (1) RU2325178C2 (de)
TW (1) TWI280881B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP702498A0 (en) * 1998-11-09 1998-12-03 Silverbrook Research Pty Ltd Image creation method and apparatus (ART77)
US20050163734A1 (en) * 2002-09-23 2005-07-28 Kim Jong S. Cosmetic composition having whitening effect comprising extract of pulsatilla radix as main ingredient
KR100667955B1 (ko) * 2004-05-07 2007-01-15 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
KR100628334B1 (ko) * 2004-07-30 2006-09-27 김송배 백두옹의 항암효과를 증진시키는 방법 및 이 방법으로제조된 항암 조성물
JP4892833B2 (ja) * 2004-12-17 2012-03-07 大正製薬株式会社 脂肪吸収抑制剤
JP5156394B2 (ja) * 2005-02-03 2013-03-06 エスケー ケミカルズ カンパニー リミテッド 脳機能改善効果を有するオキナグサ抽出物
KR100748248B1 (ko) * 2006-06-26 2007-08-10 주식회사 에스비피 백두옹으로부터 분리된 트리터펜 사포닌 및 이를 포함하는항-고형암 조성물
CN102199184B (zh) * 2011-04-07 2013-03-06 江西本草天工科技有限责任公司 一种常春藤皂苷类衍生物、其盐的制备方法及其抗肿瘤的用途
CN102178688B (zh) * 2011-04-07 2012-11-21 江西本草天工科技有限责任公司 一种常春藤皂苷类成分的制备方法及其抗肿瘤的用途
CN102633857A (zh) * 2012-04-24 2012-08-15 吉林大学 一种常春藤皂苷元的提取方法
JP2012246311A (ja) * 2012-09-05 2012-12-13 Sk Chemicals Co Ltd 脳機能改善効果を有するオキナグサ抽出物
CN104622880B (zh) * 2015-02-09 2017-05-17 南京医科大学第一附属医院 一种抗肿瘤药物组合物
CN104761610A (zh) * 2015-02-10 2015-07-08 江西本草天工科技有限责任公司 一类新型的α-常春藤皂苷衍生物及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670523A (de) * 1964-10-09
KR940000234B1 (ko) * 1989-09-04 1994-01-12 김송배 신규 항암작용을 가지는 약학적 제제 및 제조방법
US5098870A (en) * 1990-07-12 1992-03-24 Lanxide Technology Company, Lp Process for preparing self-supporting bodies having controlled porosity and graded properties and products produced thereby
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
KR0128494B1 (ko) * 1994-07-26 1998-04-04 최무섭 색전이 없는 생약 추출물-함유 줄무늬 치약 조성물
KR100205045B1 (ko) * 1996-12-05 1999-06-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
WO1999001474A1 (en) * 1997-07-02 1999-01-14 Washington State University Research Foundation Methods for the isolation of proteinase inhibitor proteins from potato tubers
KR19990016761A (ko) * 1997-08-19 1999-03-15 김송배 신규한 트리테르펜 글리코사이드 화합물, 그의 제조방법 및 그를 함유하는 항암제 조성물
KR100312622B1 (ko) * 1998-11-03 2002-02-28 김송배 생약을주성분으로한안정화된항암제조성물및그제조방법
KR100315200B1 (ko) 1998-11-10 2002-03-21 김송배 데옥시포도필로톡신을유효성분으로함유하는고형암치료제조성물
KR100340941B1 (ko) * 1999-05-14 2002-06-20 김일웅 항 종양 효과가 있는 화합물 및 그것을 함유하는 항종양제
US6767566B2 (en) * 2001-07-06 2004-07-27 Kemin Consumer Care, L.C. Method of enhancing the extraction of proteinase inhibitors
US6686456B2 (en) * 2001-07-06 2004-02-03 Kemin Foods, L.C. Method for the elimination of Kunitz and Bowman-Birk trypsin inhibitors and carboxypeptidase inhibitor from potato proteins

Also Published As

Publication number Publication date
EP1388542A1 (de) 2004-02-11
DK1388542T3 (da) 2008-01-02
AU2003208120B2 (en) 2008-09-11
TW200410704A (en) 2004-07-01
ATE373670T1 (de) 2007-10-15
MXPA03006473A (es) 2004-02-04
US8075923B2 (en) 2011-12-13
TWI280881B (en) 2007-05-11
JP4642330B2 (ja) 2011-03-02
EP1388542B1 (de) 2007-09-19
JP2004051641A (ja) 2004-02-19
CA2435524C (en) 2009-11-03
CA2435524A1 (en) 2004-01-22
CN1494910A (zh) 2004-05-12
ES2292883T3 (es) 2008-03-16
US20040082528A1 (en) 2004-04-29
AU2003208120A1 (en) 2004-02-05
KR100568607B1 (ko) 2006-04-07
RU2325178C2 (ru) 2008-05-27
CN1308000C (zh) 2007-04-04
US20050239718A1 (en) 2005-10-27
BR0302590A (pt) 2004-08-24
US7682638B2 (en) 2010-03-23
DE60316389T2 (de) 2008-06-26
RU2003122817A (ru) 2005-01-27
KR20040009172A (ko) 2004-01-31
US20100152124A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
DE60316389D1 (de) Verwendung von Hederagenin 3-O-alpha-L-rhamnopyranosyl((1->2)-Äbeta-D-glucopyranosyl(1->4)Ü-alpha-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als therapeutisches Mittel für solide Tumore
ATE306553T1 (de) Verwendung von hydroxylphenyl pyruvate dioxygenase ( hppd ) inhibitoren als selektionsmittel für pflanzentransformation
NO20075985L (no) Stabil emulsjonsforbindelse
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
CY1111867T1 (el) Ενωση ενεργοποιησης ppar και φαρμακευτικη συνθεση που περιεχει αυτη
DE60233234D1 (en) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
TNSN02053A1 (en) Shampoos with behenyl alcohol
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
DE602004026713D1 (de) Architektur zum generieren von zwischendarstellungen für programmkodekonversion
EA200701634A1 (ru) Добавки к средствам для мытья тела
NO20071378L (no) Tiazolo-naftylsyrer.
BR0312037A (pt) Oxidação de compostos orgânicos
ES2181501T3 (es) Composicion cosmetica.
DE60122337D1 (de) Verwendung von taci als antitumormittel
BRPI0510938A (pt) vitamina k1 como energizador em formulações cosméticas
CY1108630T1 (el) Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο
ATE304858T1 (de) Mischung enthaltend einen inhibitor oder suppressor eines gens und ein molekül,dass an ein expressionprodukt dieses gens bindet
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
DE60106265D1 (de) Zusammensetzung, insbensodere für kosmetika, enthaltend dhea und/oder einen chemische oder biologische vorläufer davon und einen metalloproteinase inhibitor
DE60332096D1 (de) Mikrosatellitenmarker in form von mononukleotidwiederholungen zur detektion von mikrosatelliteninstabilität
NO20074805L (no) Fremgangsmate for a identifisere PDE11-modulatorer
DE60221323D1 (de) Dokumentenerzeugungsverfahren, Druckgerät angepasst an dieses Verfahren, und Rechnerprogrammelement, das einen Programmkode zur Ausführung des Verfahrens enthält
EP1642969A4 (de) Fluoreszenzprotein und pigmentprotein
ECSP056103A (es) Tratamiento de pigmentos de alto rendimiento
RS20060195A (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition